Clinical Research Directory

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Sponsor: City of Hope Medical Center

Summary

The prognosis of patients with esophageal squamous cell carcinoma (ESCC) who develop post-operative early tumor recurrence is often relatively poor. Therefore, biomarker that can detect micro metastases before the start of treatment is required. Epigenomic alterations such as DNA methylation have attracted attention as promising biomarkers. The investigators aim to predict early recurrence based on whole genome DNA methylation analysis of esophageal cancer.

Official title: Predicting Postoperative Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Key Details

Conditions

Interventions

Locations (2)